Skip to main content

Advertisement

SpringerLink
Log in

Occurrence of intraocular air bubbles during intravitreal injections for retinopathy of prematurity

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

This study aims to present five cases with retinopathy of prematurity (ROP) who were found to have intraocular air bubbles after intravitreal injection (IVI) treatment. The medical records of 148 infants who underwent IVI for ROP were retrospectively reviewed and the ones who demonstrated post-injection intraocular air bubble formation were recruited. Of the 148 patients (31 babies received ranibizumab, 20 babies received aflibercept, 97 babies received bevacizumab), five were found to have intraocular air bubbles right after the IVI. Two infants received intravitreal ranibizumab and three received intravitreal bevacizumab injections. Although intraocular pressure increased temporarily, no intraocular sterile or infective reactions were observed in the postoperative period. The air bubble was found to resorb spontaneously within 72 h. The occurrence rate of the intravitreal air bubbles in our series was 3.37 % despite previously not been reported in the literature. Due to the intravitreal air injection risk, it is important to be more careful while preparing the intravitreal medication before treatment in premature babies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lad EM, Hernandez-Boussard T, Morton JM, Moshfeghi DM (2009) Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am J Ophthalmol 148(3):451–458

    Article  PubMed  Google Scholar 

  2. Cryotherapy for Retinopathy of Prematurity Cooperative Group (1990) Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome—structure and function. Arch Ophthalmol 108(10):1408–1416

    Article  Google Scholar 

  3. Early Treatment for Retinopathy of Prematurity Cooperative Group (2003) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121(12):1684–1694

    Article  Google Scholar 

  4. Mintz-Hittner HA, Kennedy KA, Chuang AZ, Beat-rop Cooperative Group (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603–615

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lai TY, Liu S, Das S, Lam DS (2015) Intravitreal injection-technique and safety. Asia Pac J Ophthalmol (Phila) 4:321–328

    Article  CAS  Google Scholar 

  6. Kuniyoshi K, Sugioka K, Sakuramoto H, Kusaka S, Wada N, Shimomura Y (2014) Intravitreal injection of bevacizumab for retinopathy of prematurity. Jpn J Ophthalmol 58(3):237–243

    Article  CAS  PubMed  Google Scholar 

  7. Wu WC, Kuo HK, Yeh PT, Yang CM, Lai CC, Chen SN (2013) An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan. Am J Ophthalmol 155(1):150–158

    Article  CAS  PubMed  Google Scholar 

  8. Somner JE, Mansfield D (2009) In advertent injection of intravitreal air during intravitreal Lucentis injection for wet age-related macular degeneration: an un described complication. Eye 23(8):1744

    Article  CAS  PubMed  Google Scholar 

  9. Castellanos MA, Schwartz S, García-Aguirre G, Quiroz-Mercado H (2013) Short-term out come after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity. Br J Ophthalmol 97(7):816–819

    Article  PubMed  Google Scholar 

  10. Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR (2015) Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology 122(5):1008–1015

    Article  PubMed  PubMed Central  Google Scholar 

  11. Yetik H, Gunay M, Sirop S, Salihoglu Z (2015) Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity—27 month follow-up results from Turkey. Graefes Arch Clin Exp Ophthalmol 253(10):1677–1683

    Article  CAS  PubMed  Google Scholar 

  12. Shima C, Sakaguchi H, Gomi F, Kamei M, Ikuno Y, Oshima Y, Sawa M, Tsujikawa M, Kusaka S, Tano Y (2008) Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86(4):372–376

    Article  PubMed  Google Scholar 

  13. Yun C, Oh J, Hwang SY, Kim SW, Huh K (2015) Subconjunctival hemorrhage after intravitreal injection of anti-vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol 253(9):1465–1470

    Article  CAS  PubMed  Google Scholar 

  14. Erdogan G, Gunay BO, Unlu C, Gunay M, Ergin A (2015) Management of iatrogenic crystalline lens injury occurred during intravitreal injection. Int Ophthalmol: 1–4 [Epub ahead of print]

  15. Weismann LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS et al (1994) Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr 125:922–930

    Article  Google Scholar 

Download references

Funding

The authors did not receive any financial support from any public or private sources. The authors have no financial or proprietary interest in a product, method or material described herein.

Author information

Authors and Affiliations

  1. Eye Department, Adana Numune Training and Research Hospital, Serinevler Mah. Ege Bağatur Bulvarı Yüreğir, 06520, Adana, Turkey

    Emine Alyamac Sukgen & Yusuf Kocluk

  2. Turkish Republic Ministry of Health Zeynep Kamil Gynecology and Pediatrics Education and Research Hospital, Uskudar, Istanbul, Turkey

    Murat Gunay

Authors
  1. Emine Alyamac Sukgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Murat Gunay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusuf Kocluk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emine Alyamac Sukgen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sukgen, E.A., Gunay, M. & Kocluk, Y. Occurrence of intraocular air bubbles during intravitreal injections for retinopathy of prematurity. Int Ophthalmol 37, 215–219 (2017). https://doi.org/10.1007/s10792-016-0257-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0257-9

Keywords

Search

Navigation